§ 13F · FUND PROFILE
Paradigm Biocapital Advisors LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 30Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$3917.8T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | NUVL | NUVALENT INC | 5.27M | $530.1T | 13.5% | NEW |
| 2 | RVMD | REVOLUTION MEDICINES INC | 6.64M | $529.2T | 13.5% | NEW |
| 3 | ACLX | ARCELLX INC | 5.72M | $373.2T | 9.5% | NEW |
| 4 | GMAB | GENMAB A/S | 7.04M | $216.8T | 5.5% | NEW |
| 5 | TARS | TARSUS PHARMACEUTICALS INC | 2.56M | $209.8T | 5.4% | NEW |
| 6 | ABVX | ABIVAX SA | 1.42M | $191.2T | 4.9% | NEW |
| 7 | OLMA | OLEMA PHARMACEUTICALS INC | 7.54M | $188.6T | 4.8% | NEW |
| 8 | PCVX | VAXCYTE INC | 4.07M | $187.7T | 4.8% | NEW |
| 9 | XBI | SPDR SERIES TRUST | 1.50M | $182.9T | 4.7% | NEW |
| 10 | CDTX | CIDARA THERAPEUTICS INC | 760K | $167.8T | 4.3% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE PARADIGM SIGNAL
AC read
Paradigm Biocapital Advisors LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed